Philip E. Castle, PhD, MPH
Global Cervical Cancer Control: Will We Ever Get That Rock To The Top Of The Hill?
Dr. Castle was appointed Director of the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI) in July 2020. Dr. Castle earned a Ph.D. in Biophysics in 1995 and a Master’s in Public Health in 2000, both at The Johns Hopkins University, Baltimore, Maryland. Dr. Castle also rejoins the NCI as a senior investigator in the Division of Cancer Epidemiology and Genetics, focused on discovery, development, and evaluation/validation of new technologies for the prevention of cancer. Dr. Castle is conducting research studies on cancer screening and prevention in Mozambique, Rwanda, and India as well as continuing his work with Kaiser Permanente Northern California.
Vikrant Sahasrabuddhe, MBBS, MPH, DrPH
Advancing Prevention Clinical Research on Cervical Cancer and HPV-related Cancers
Dr. Vikrant Sahasrabuddhe is Deputy Chief of the Breast and Gynecologic Cancer Research Group and Program Director in the Division of Cancer Prevention at the National Cancer Institute overseeing prevention clinical research on cervical cancer and other human papillomavirus (HPV)-related cancers. Dr. Sahasrabuddhe provides scientific direction and strategic guidance for efforts on optimization of clinic-based and population-based precision prevention strategies for cervical cancer and other HPV-related cancers and building the evidence base for their implementation in the United States and globally.
Joel Palefsky, MD
Results of the ANCHOR Study: Opportunities and Challenges in Prevention of Anal Cancer
Joel M. Palefsky, MD is an expert in infectious diseases and in cancers associated with these diseases. His expertise includes treating anal dysplasia, a precancerous condition that may lead to anal cancer and that is caused by the human papillomavirus (HPV). Palefsky studies the biology of HPV and the Epstein-Barr virus, and is active in the development of new treatments. Palefsky earned his medical degree at McGill University and completed a fellowship in infectious disease at Stanford University. Palefsky is founder and president of the International Anal Neoplasia Society and president-elect of the International Papillomavirus Society.